Dolo 650 Tablet helps relieve pain and fever by blocking the release of certain chemical messengers responsible for fever and pain. It is used to treat headaches, migraine, nerve pain, toothache, sore throat, period (menstrual) pains.
Dolo 650 Tablet has been one of the most widely prescribed paracetamol-based medications during the COVID-19 pandemic. It should be taken regularly as per the doctor’s advice. Take it with food to avoid an upset stomach. It may be taken alone or in combination with other medications. However, no more than four doses of Dolo 650 Tablet can be taken in 24 hours with a gap of at least 4 hours between two doses. Please do not take it for longer than recommended.
The CBDT on Wednesday accused the makers of the widely-known Dolo-650 medicine tablet of indulging in "unethical practices" and distributing freebies of about 1,000 crore to doctors and medical professionals in exchange for promoting products made by the pharmaceutical group.
The claims came after the Income Tax department on July 6 raided 36 premises of Bengaluru-based Micro Labs Ltd. across nine states.The Central Board of Direct Taxes (CBDT) said in a statement that the department seized "unaccounted" cash of 1.20 crore and gold and diamond jewellery worth 1.40 crore.The CBDT is the administrative body for the I-T department.An email sent to Micro Labs Ltd. seeking its response to the claims made by the department remained unanswered.
"During the course of the search operations, substantial incriminating evidence, in the form of documents and digital data, has been found and seized.
"The initial gleaning of the evidence has revealed that the group has been debiting in its books of account unallowable expenses on account of the distribution of freebies to medical professionals under the head "sales and promotion")," it said.
The CBDT alleged these "freebies" included travel expenses, perquisites, gifts, etc. to doctors and medical professionals for promoting the group's products under the heads "promotion and propaganda," "seminars and symposiums," "medical advisories," etc. "The evidence indicates that the group has adopted unethical practises to promote its products and brands." "The quantum of such freebies detected is estimated to be around 1,000 crore," it said.
While the CBDT statement did not identify the group, sources confirmed it to be Micro Labs Ltd.
Dolo-650, an analgesic (pain killer) and antipyretic (fever-reducing) oral tablet, was being extensively prescribed by doctors and medical shop owners for coronavirus patients to reduce pain and fever, common symptoms experienced by those infected.
The company's website showcased a news article, published in February, that said: "The company has sold 350 crore tablets (of Dolo-650) since the COVID-19 outbreak in the year 2020, and earned revenues of 400 crore in a year." The CMD of the company, Dilip Surana, was quoted in the story.
The CBDT also alleged certain other irregularities on the part of the group that has a presence in more than 50 countries and manufactures of pharma products and active pharmaceutical ingredients (API).
The group claimed that it "artificially inflated deductions under special provisions in respect of certain incomes, by resorting to suppression of expenses and over-appropriation of revenue to the unit eligible for such deduction." Various other means of tax evasion, including inadequate allocation of research and development expenses to eligible units and inflated claims of weighted deduction under section 35 (2AB), have also been detected, the CBDT said.
The quantum of tax sought to be "evaded" through such means is estimated at over 300 crore, the statement said. It added that the department also found instances of "violation" of provisions of the tax deduction at source (TDS) under section 194C of the I-T Act in respect of the transactions entered into with third-party bulk drug manufacturers.
You must be logged in to post a comment.